Vol 6, No 3 (June 2017): Chinese Clinical Oncology (Pancreas Adenocarcinoma-I-Guest Editors: Eileen M. O’Reilly, Lei Zheng)

Preface on Pancreas Adenocarcinoma1

Preface: pancreas adenocarcinoma
Eileen M. O’Reilly, Lei Zheng
Chinese Clinical Oncology
 2017;
6
(3)
:23

Review Article on Pancreas Adenocarcinoma1

Epidemiology of pancreatic adenocarcinoma
Priya K. Simoes, Sara H. Olson, Amethyst Saldia, Robert C. Kurtz
Chinese Clinical Oncology
 2017;
6
(3)
:24
Preclinical models of pancreatic ductal adenocarcinoma
Benjamin D. Krempley, Kenneth H. Yu
Chinese Clinical Oncology
 2017;
6
(3)
:25
Adjuvant and neoadjuvant therapy for resectable pancreatic adenocarcinoma
Davendra P. S. Sohal
Chinese Clinical Oncology
 2017;
6
(3)
:26
Multimodality management of borderline resectable pancreatic adenocarcinoma
Laura R. Prakash, Matthew H. G. Katz
Chinese Clinical Oncology
 2017;
6
(3)
:27
Radiation therapy in the management of pancreatic adenocarcinoma: review of current evidence and future opportunities
Tyler P. Robin, Karyn A. Goodman
Chinese Clinical Oncology
 2017;
6
(3)
:28
Best practices for the treatment of metastatic pancreatic adenocarcinoma: the therapeutic landscape in 2017
Pelin Cinar, Andrew H. Ko
Chinese Clinical Oncology
 2017;
6
(3)
:29
Pancreas adenocarcinoma: novel therapeutics
Benjamin A. Krantz, Kenneth H. Yu, Eileen M. O’Reilly
Chinese Clinical Oncology
 2017;
6
(3)
:30
Rational combinations of immunotherapy for pancreatic ductal adenocarcinoma
Alex B. Blair, Lei Zheng
Chinese Clinical Oncology
 2017;
6
(3)
:31
Palliative care and advance care planning for pancreas and other cancers
Rajiv Agarwal, Andrew S. Epstein
Chinese Clinical Oncology
 2017;
6
(3)
:32

Review Article

Isocitrate dehydrogenase mutation as a therapeutic target in gliomas
Catherine H. Han, Tracy T. Batchelor
Chinese Clinical Oncology
 2017;
6
(3)
:33

Disclosure:

1. The series “Pancreas Adenocarcinoma I” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Eileen M. O’Reilly and Lei Zheng served as the unpaid Guest Editors for the series.